SinoMab BioScience Ltd 3681.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 03/28/24 CTT
1.56quote price arrow up+0.04 (+2.63%)
Volume
136,800
52 week range
1.03 - 2.07
Loading...
  • Open1.52
  • Day High1.57
  • Day Low1.51
  • Prev Close1.52
  • 52 Week High2.07
  • 52 Week High Date04/04/23
  • 52 Week Low1.03
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap205.2M
  • Shares Out1,091.76M
  • 10 Day Average Volume208,250
  • Dividend-
  • Dividend Yield-
  • Beta0.14
  • YTD % Change-7.14

KEY STATS

  • Open1.52
  • Day High1.57
  • Day Low1.51
  • Prev Close1.52
  • 52 Week High2.07
  • 52 Week High Date04/04/23
  • 52 Week Low1.03
  • 52 Week Low Date10/26/23
  • Market Cap205.2M
  • Shares Out1,091.76M
  • 10 Day Average Volume208,250
  • Dividend-
  • Dividend Yield-
  • Beta0.14
  • YTD % Change-7.14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.26
  • P/E (TTM)-5.93
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SinoMab BioScience Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE). The Company’s product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is developing drugs for the treatment of RA, systemic lupus erythematosus (SLE)...
Shui On Leung
Chairman of the Board, Chief Executive Officer
Jianping Hua
Chief Financial Officer
Address
22/F
Yugang Building, 90 Jaffe Road, Wanchai
Hong Kong